Gentiva Health Services
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Gentiva Health Services' revenues will drop -4.7% and EPS will wither -42.9%.
The average estimate for revenue is $435.4 million. On the bottom line, the average EPS estimate is $0.28.
Last quarter, Gentiva Health Services reported revenue of $435.7 million. GAAP reported sales were 3.4% lower than the prior-year quarter's $451.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.24. GAAP EPS of $0.16 for Q1 were 63% lower than the prior-year quarter's $0.43 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 46.5%, 230 basis points worse than the prior-year quarter. Operating margin was 7.9%, 350 basis points worse than the prior-year quarter. Net margin was 1.1%, 190 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $1.75 billion. The average EPS estimate is $1.14.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 294 members rating the stock outperform, and 17 members rating it underperform. Among 96 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 91 give Gentiva Health Services a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentiva Health Services is hold, with an average price target of $7.40.
- Add Gentiva Health Services to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
The Only Book Value Bargain in the Healthcare Sector and Why You Should Avoid It
Based on book value this is the cheapest stock in the healthcare sector. However, just because it's cheap doesn't mean you'll want anything to do with it.
3 Stocks Near 52-Week Highs Worth Selling
Are these three stocks sells or belles? You be the judge!
What Sparked Gentiva Health Services, Inc. Stock's Surprising Surge
Gentiva shares soar after igniting a supposed bidding war for the company. Find out what this means for Gentiva's shareholders.